Frankfurt am Main, Germany

Uwe Boysen


Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 165(Granted Patents)


Company Filing History:


Years Active: 1979-1982

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Uwe Boysen: Innovator in Hemoglobin Research

Introduction

Uwe Boysen is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of hemoglobin research, particularly in the development of innovative hemoglobin preparations for medical applications. With a total of 2 patents, his work focuses on enhancing the efficacy and safety of hemoglobin-based therapies.

Latest Patents

Boysen's latest patents include the "Preparation of coupled hemoglobin molecules" and "Hemoglobin preparation with increased oxygen release." The first patent describes a method for coupling hemoglobin molecules to increase their intravascular residence times without significantly diminishing their oxygen transport ability. This is achieved by using dialdehydes to couple hemoglobin molecules and serum proteins, followed by a series of purification steps. The second patent outlines a hemoglobin preparation suitable for intravenous injection, which boasts increased oxygen release compared to traditional erythrocytes or hemoglobin solutions. This preparation involves a detailed process of washing, hemolysis, and treatment with pyridoxal phosphate, resulting in a product with a retention time in the blood vessels of about 2 to 9 hours.

Career Highlights

Uwe Boysen is currently associated with Biotest-Serum-Institut GmbH, where he continues to advance his research in hemoglobin preparations. His innovative approaches have the potential to significantly impact medical treatments involving oxygen transport and delivery.

Collaborations

Throughout his career, Boysen has collaborated with esteemed colleagues such as Klaus Bonhard and Hans Schleubner. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking medical solutions.

Conclusion

Uwe Boysen's contributions to hemoglobin research exemplify the importance of innovation in medical science. His patents reflect a commitment to improving patient care through advanced hemoglobin preparations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…